checkAd
    SpringWorks Therapeutics Aktie
    41,46
     
    USD
    -2,70 %
    -1,15 USD
    Letzter Kurs 02:00:00 Nasdaq
    41,44
     
    USD
    12.700 STK
    Geldkurs 31.05.24
    41,45
     
    USD
    300 STK
    Briefkurs 31.05.24
    ISIN: US85205L1070 · WKN: A2PRLN · SYM: SWTX · USA

    Neueste Nachrichten

    SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    23.05.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
    08.05.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
    02.05.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    24.04.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
    18.04.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN
    04.03.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
    29.02.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
    27.02.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics to Present at Upcoming Investor Conferences
    22.02.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    31.01.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
    08.01.24 · globenewswire · SpringWorks Therapeutics
    SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    21.12.23 · globenewswire · SpringWorks Therapeutics